Ke, X. and Ma, T. (2025) Protective Effect of Liraglutide on Early Renal Fibrosis in Diabetes Mice. Journal of Biosciences and Medicines, 13, 84-91. doi: 10.4236/jbm.2025.131008 .

Scientists uncover how Ffar4 regulates sugar cravings through gut microbiota, revealing pantothenate as a key mediator to ...

The advent of anti-obesity medications such as semaglutide that act on the receptor for glucagon-like peptide ... acting as the primary communication pathway between the gut and the brain.

Semaglutide and tirzepatide are both glucagon-like peptide-1 receptor agonists ... It feels bad, and that’s part of what makes it work. But that signal, like you’re learning from your own ...

Biomedical researchers at Ohio University have received National Institutes of Health (NIH) funding to investigate the role ...

Some drugs can activate AMPK, most prominently metformin, which is approved for diabetes and being trialed in dementia. Less well-known is aldometanib, developed by Lin’s team, which blocks aldolase, ...

Additional signaling pathways, including phosphatidylinositol3-kinase/protein ... AKT, protein kinase B; ERS, endoplasmic reticulum stress; GLP-1, Glucagon-like peptide 1; GIPR, gastric inhibitory ...

Explore how inhibiting myostatin can promote muscle mass in men, addressing sarcopenia, GLP-1 medication effects, and aging ...

Semaglutide is an analog of glucagon-like peptide-1 (GLP-1), an endogenously ... These interactions are hypothesized to influence energy homeostasis, cellular metabolism, and signaling pathways ...